3593 HOGY MEDICAL CO.,LTD. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

3593

TSE Prime

HOGY MEDICAL CO.,LTD.

5,640

JPY

-40

(-0.70%)

Dec 5, 12:49 pm JST

36.35

USD

Dec 4, 10:49 pm EST

Result

PTS

outside of trading hours

5,640

Dec 5, 12:48 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	36,778	6,135	6,285	4,370	153.0	68	Apr 12, 2022	J-GAAP
Mar, 2023	38,981	6,634	6,653	4,316	178.0	71	Apr 12, 2023	J-GAAP
Mar, 2024	39,100	4,169	4,245	2,804	115.6	80	Apr 10, 2024	J-GAAP
Mar, 2025	39,138	3,810	3,645	1,520	68.0	80	Apr 24, 2025	J-GAAP
Mar, 2026 Guidance	39,240	2,770	2,590	2,030	94.2	95	Oct 15, 2025	J-GAAP
YoY	+0.3%	-27.3%	-28.9%	+33.6%	+38.5%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2021	Apr 10, 2020	38,700	6,400	6,830	5,300	68	J-GAAP
	Oct 12, 2020	36,310	5,490	5,930	4,980	68	J-GAAP
Results	Apr 12, 2021	36,504	5,632	5,988	4,959	68	J-GAAP
Mar, 2022	Apr 12, 2021	Available in future release
	Oct 12, 2021
Results	Apr 12, 2022
Mar, 2023	Apr 12, 2022
	Jan 16, 2023
Results	Apr 12, 2023
Mar, 2024	Apr 12, 2023
	Jan 16, 2024
Results	Apr 10, 2024
Mar, 2025	Apr 10, 2024
	Mar 31, 2025
Results	Apr 24, 2025
Mar, 2026	Apr 24, 2025	41,790	4,300	4,430	3,020	95	J-GAAP
	Oct 15, 2025	39,240	2,770	2,590	2,030	95	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2001	21,801	+3.3	Available in future release
Mar, 2002	22,891	+5.0
Mar, 2003	23,886	+4.3
Mar, 2004	24,844	+4.0
Mar, 2005	24,961	+0.5
Mar, 2006	26,434	+5.9
Mar, 2007	27,293	+3.2
Mar, 2008	29,010	+6.3
Mar, 2009	31,009	+6.9
Mar, 2010	31,339	+1.1
Mar, 2011	31,311	-0.1
Mar, 2012	31,873	+1.8
Mar, 2013	33,094	+3.8
Mar, 2014	34,793	+5.1
Mar, 2015	35,233	+1.3
Mar, 2016	36,568	+3.8
Mar, 2017	36,859	+0.8
Mar, 2018	36,918	+0.2
Mar, 2019	36,658	-0.7
Mar, 2020	37,232	+1.6
Mar, 2021	36,504	-2.0
Mar, 2022	36,778	+0.8
Mar, 2023	38,981	+6.0
Mar, 2024	39,100	+0.3
Mar, 2025	39,138	+0.1
Mar, 2026 Guidance	39,240	+0.3	2,770	-27.3	2,590	-28.9	94.2	+38.5

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	39,100	4,169	10.7	3.30	2.77	0.39	115.6
Mar, 2025	39,138	3,810	9.73	1.89	1.54	0.40	68.0
Mar, 2026 Guidance	39,240	2,770	7.06	2.77	2.14	0.41	94.2

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	39,138	8,784	9,055	6,043	198.3
Fiscal Year	Mar, 2025	Mar, 2016	Mar, 2014	Mar, 2019	Mar, 2019

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	19,780	3,449	3,491	2,084	85.9	36	Apr 12, 2023	J-GAAP
Oct - Mar, 2023	19,564	1,794	1,872	1,072	44.2	40	Apr 10, 2024	J-GAAP
Oct - Mar, 2024	19,519	1,727	1,609	-347	-15.5	40	Apr 24, 2025	J-GAAP
Oct - Mar, 2025 Guidance	20,383	1,493	1,450	1,123	52.1	47.50	Oct 15, 2025	J-GAAP
YoY	+4.4%	-13.5%	-9.9%	－	－

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	6,634	7,225	9,176	-1,951	-3,142	18,351	17.96	J-GAAP
Mar, 2024	4,169	3,855	7,117	-3,262	-3,892	18,623	18.62	J-GAAP
Mar, 2025	3,810	7,638	11,555	-3,917	-5,455	21,334	21.79	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2023	19,536	2,375	2,373	1,732	71.4	55.9	Oct 12, 2023	J-GAAP
Apr - Sep, 2024	19,619	2,083	2,036	1,867	80.6	55.9	Oct 10, 2024	J-GAAP
Apr - Sep, 2025	18,857	1,277	1,140	907	42.1	44.0	Oct 27, 2025	J-GAAP
YoY	-3.9%	-38.7%	-44.0%	-51.4%	-47.7%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	10,218	1,112	1,214	877	36.2	10.9	Jan 16, 2024	J-GAAP
Jan - Mar, 2024	9,346	682	658	195	8.0	7.3	Apr 10, 2024	J-GAAP
Apr - Jun, 2024	9,725	1,335	1,405	1,006	41.5	13.7	Jul 10, 2024	J-GAAP
Jul - Sep, 2024	9,894	748	631	861	37.2	7.6	Oct 10, 2024	J-GAAP
Oct - Dec, 2024	10,397	1,323	1,233	869	38.4	12.7	Jan 16, 2025	J-GAAP
Jan - Mar, 2025	9,122	404	376	-1,216	-54.4	4.4	Apr 24, 2025	J-GAAP
Apr - Jun, 2025	9,375	950	899	732	34.0	10.1	Jul 25, 2025	J-GAAP
Jul - Sep, 2025	9,482	327	241	175	8.1	3.4	Oct 27, 2025	J-GAAP
YoY	-4.2%	-56.3%	-61.8%	-79.7%	-78.1%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2020	9,962	+2.9	Available in future release
Jan - Mar, 2021	8,808	-4.0
Apr - Jun, 2021	8,895	+6.2
Jul - Sep, 2021	9,033	-3.5
Oct - Dec, 2021	9,882	-0.8
Jan - Mar, 2022	8,968	+1.8
Apr - Jun, 2022	9,447	+6.2
Jul - Sep, 2022	9,754	+8.0
Oct - Dec, 2022	10,334	+4.6
Jan - Mar, 2023	9,446	+5.3
Apr - Jun, 2023	9,679	+2.5
Jul - Sep, 2023	9,857	+1.1
Oct - Dec, 2023	10,218	-1.1
Jan - Mar, 2024	9,346	-1.1
Apr - Jun, 2024	9,725	+0.5
Jul - Sep, 2024	9,894	+0.4
Oct - Dec, 2024	10,397	+1.8
Jan - Mar, 2025	9,122	-2.4
Apr - Jun, 2025	9,375	-3.6
Jul - Sep, 2025	9,482	-4.2	327	-56.3	241	-61.8	8.1	-78.2

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	10,397	2,570	2,746	3,636	118.2
Fiscal Year	Dec, 2024	Dec, 2013	Dec, 2013	Sep, 2018	Sep, 2018

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	3,446.71	81.8	102,180	83,606	91,142	0.09	Apr 12, 2023	J-GAAP
Mar, 2024	3,547.47	86.1	100,041	86,111	67,762	0.07	Apr 10, 2024	J-GAAP
Mar, 2025	3,447.34	75.9	97,895	74,324	56,552	0.18	Apr 24, 2025	J-GAAP
Apr - Sep, 2025	ー	77.2	94,919	73,294	56,517	0.17	Oct 27, 2025	J-GAAP

HOGY MEDICAL CO.,LTD.(3593) Financial Results